Urination Disorders Completed Phase 4 Trials for Solifenacin (DB01591)

IndicationStatusPhase
DBCOND0033189 (Urination Disorders)Completed4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01833663Effectiveness and Safety Study of Solifenacin Succinate and Solifenacin Succinate + Estrogen to Treat OAB in Postmenopausal WomenTreatment